182 related articles for article (PubMed ID: 28395796)
1. Derivation of human iPS cell lines from monozygotic twins in defined and xeno free conditions.
Uhlin E; Rönnholm H; Day K; Kele M; Tammimies K; Bölte S; Falk A
Stem Cell Res; 2017 Jan; 18():22-25. PubMed ID: 28395796
[TBL] [Abstract][Full Text] [Related]
2. Generation of human iPS cell line CTL07-II from human fibroblasts, under defined and xeno-free conditions.
Kele M; Day K; Rönnholm H; Schuster J; Dahl N; Falk A
Stem Cell Res; 2016 Nov; 17(3):474-478. PubMed ID: 27789397
[TBL] [Abstract][Full Text] [Related]
3. Generation of a disease-specific iPS cell line derived from a patient with Charcot-Marie-Tooth type 2K lacking functional GDAP1 gene.
Martí S; León M; Orellana C; Prieto J; Ponsoda X; López-García C; Vílchez JJ; Sevilla T; Torres J
Stem Cell Res; 2017 Jan; 18():1-4. PubMed ID: 28395795
[TBL] [Abstract][Full Text] [Related]
4. Establishment of an induced pluripotent stem cell (iPSC) line from a patient with Clozapine-responder Schizophrenia.
Marcatili M; Marsoner F; D'Agostino A; Karnavas T; Bottai D; Scarone S; Conti L
Stem Cell Res; 2016 Nov; 17(3):630-633. PubMed ID: 27934596
[TBL] [Abstract][Full Text] [Related]
5. Generation of a human induced pluripotent stem cell (iPSC) line from a 64year old male patient with multiple schwannoma.
Zhang S; Lv Z; Hu Y; Liu L; Gong W; Li Q; Wu H
Stem Cell Res; 2017 Mar; 19():49-51. PubMed ID: 28413006
[TBL] [Abstract][Full Text] [Related]
6. Generation of human iPSCs from urine derived cells of a non-affected control subject.
Afzal MZ; Gartz M; Klyachko EA; Khan SS; Shah SJ; Gupta S; Shapiro AD; Vaughan DE; Strande JL
Stem Cell Res; 2017 Jan; 18():33-36. PubMed ID: 28395799
[TBL] [Abstract][Full Text] [Related]
7. Development of human induced pluripotent stem cell (iPSC) line from a 60year old female patient with multiple schwannoma.
Zhang S; Lv Z; Liu Y; Li Q; Gong W; Liu L; Wu H
Stem Cell Res; 2017 Mar; 19():31-33. PubMed ID: 28413001
[TBL] [Abstract][Full Text] [Related]
8. Characterization of human induced pluripotent stem cell (iPSC) line from a 72year old male patient with later onset Alzheimer's disease.
Zhang S; Lv Z; Zhang S; Liu L; Li Q; Gong W; Sha H; Wu H
Stem Cell Res; 2017 Mar; 19():34-36. PubMed ID: 28413002
[TBL] [Abstract][Full Text] [Related]
9. Generation of MERRF patient-derived induced pluripotent stem cell line iMERRF-C7.
Liang D; Hu H; Xu T; Wang Y; Hu P; Xu Z
Stem Cell Res; 2016 Nov; 17(3):616-618. PubMed ID: 27934592
[TBL] [Abstract][Full Text] [Related]
10. Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.
Wang J; Hao J; Bai D; Gu Q; Han W; Wang L; Tan Y; Li X; Xue K; Han P; Liu Z; Jia Y; Wu J; Liu L; Wang L; Li W; Liu Z; Zhou Q
Stem Cell Res Ther; 2015 Nov; 6():223. PubMed ID: 26564165
[TBL] [Abstract][Full Text] [Related]
11. Generation and characterization of an induced pluripotent stem cell (iPSC) line from a patient with clozapine-resistant Schizophrenia.
Marsoner F; Marcatili M; Karnavas T; Bottai D; D'Agostino A; Scarone S; Conti L
Stem Cell Res; 2016 Nov; 17(3):661-664. PubMed ID: 27934603
[TBL] [Abstract][Full Text] [Related]
12. A feeder- and xeno-free human induced pluripotent stem cell line obtained from primary human dermal fibroblasts with epigenetic repression of reprogramming factors expression: GPCCi001-A.
Lach MS; Wroblewska JP; Augustyniak E; Kulcenty K; Suchorska WM
Stem Cell Res; 2017 Apr; 20():34-37. PubMed ID: 28395738
[TBL] [Abstract][Full Text] [Related]
13. Generation of human iPSCs from urine derived cells of a patient with a novel homozygous PAI-1 mutation.
Afzal MZ; Gartz M; Klyachko EA; Khan SS; Shah SJ; Gupta S; Shapiro AD; Vaughan DE; Strande JL
Stem Cell Res; 2016 Nov; 17(3):657-660. PubMed ID: 27934602
[TBL] [Abstract][Full Text] [Related]
14. Generation of a clonal induced pluripotent stem cell (iPSC) line expressing the mutant MECP2 allele from a Rett Syndrome patient fibroblast line.
Hunihan L; Brown J; Cacace A; Fernandes A; Weston A
Stem Cell Res; 2017 Apr; 20():67-69. PubMed ID: 28395743
[TBL] [Abstract][Full Text] [Related]
15. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
[TBL] [Abstract][Full Text] [Related]
16. Reprogramming of Human Fibroblasts with Non-integrating RNA Virus on Feeder-Free or Xeno-Free Conditions.
Lieu PT
Methods Mol Biol; 2015; 1330():47-54. PubMed ID: 26621588
[TBL] [Abstract][Full Text] [Related]
17. Sendai Virus-Based Reprogramming of Mesenchymal Stromal/Stem Cells from Umbilical Cord Wharton's Jelly into Induced Pluripotent Stem Cells.
Miere C; Devito L; Ilic D
Methods Mol Biol; 2016; 1357():33-44. PubMed ID: 26246353
[TBL] [Abstract][Full Text] [Related]
18. Establishment of induced pluripotent stem cell (iPSC) line from 55-year old male patient with hemorrhagic Moyamoya disease.
Cardano M; Marsoner F; Marcatili M; Karnavas T; Zasso J; Lanterna LA; Conti L
Stem Cell Res; 2016 Nov; 17(3):623-626. PubMed ID: 27934594
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a human iPSC line (MUSIi007-A) from peripheral blood of normal individual using Sendai viral vectors.
Potirat P; Wattanapanitch M; Kheolamai P; Issaragrisil S
Stem Cell Res; 2018 Oct; 32():43-46. PubMed ID: 30172906
[TBL] [Abstract][Full Text] [Related]
20. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
